```html

Neurocysticercosis – A Comprehensive Medical Guide

Overview

Neurocysticercosis (NCC) is an infection of the central nervous system (CNS) caused by the larval stage (cysticerci) of the pork tapeworm Taenia solium. The parasites form fluid‑filled cysts in the brain, spinal cord, or surrounding meninges. NCC is the most common cause of acquired epilepsy in the developing world and represents a major public‑health problem in regions where sanitation is poor and pork consumption is common.

Who it affects: Anyone can become infected, but the disease is most prevalent in low‑ and middle‑income countries of Latin America, sub‑Saharan Africa, and Asia. In the United States, most cases occur in immigrants or travelers returning from endemic areas.

Prevalence: The World Health Organization (WHO) estimates that >50 million people worldwide are infected with T. solium, and up to 2.5 million have NCC. In some endemic regions, NCC accounts for 30 %–50 % of all seizures. (Sources: WHO, CDC, CDC).

Symptoms

Symptoms depend on the number, size, location of cysts, and the host’s immune response. They usually appear weeks to years after infection. Below is a complete list with brief explanations.

Neurological symptoms

• Seizures – most common (up to 80 % of symptomatic patients). Can be focal or generalized.
• Headache – often persistent, worsens with lying down; may indicate raised intracranial pressure.
• Focal neurological deficits – weakness, numbness, or visual field loss when cysts compress specific brain regions.
• Altered mental status – confusion, lethargy, or coma in severe cases.
• Ataxia – loss of coordination when cerebellar pathways are involved.
• Movement disorders – tremor or dystonia (rare).

Signs of meningitis or encephalitis

• Neck stiffness, photophobia, fever – especially when cysts rupture releasing antigens.
• Vomiting or nausea due to increased intracranial pressure.

Eye involvement

• Vision loss or double vision if cysts develop in the optic pathways or sub‑retinal space.

Systemic symptoms

• Fever, malaise, and weight loss are uncommon but may occur during an inflammatory reaction.

Causes and Risk Factors

Pathogenesis

Humans acquire NCC in two ways:

1. Ingestion of T. solium eggs – usually from fecally contaminated food, water, or hands after a person with an adult tapeworm defecates. The eggs hatch in the intestine, release oncospheres, which penetrate the intestinal wall and travel via the bloodstream to the CNS.
2. Autoinfection – a person already harboring an intestinal tapeworm may accidentally swallow his own eggs (poor hygiene).

The larvae develop into cysticerci that lodge in brain parenchyma, ventricular system, or subarachnoid space.

Key risk factors

• Living in or traveling to endemic areas with inadequate sanitation.
• Consumption of undercooked pork containing cysticerci (causes intestinal tapeworm, not NCC directly, but increases risk of autoinfection).
• Poor hand‑washing practices, especially after handling raw pork or using the toilet.
• Close contact with a tapeworm carrier (e.g., a family member with adult T. solium).
• Immunosuppression – may worsen disease severity.

Diagnosis

Diagnosing NCC requires a combination of clinical suspicion, neuroimaging, serology, and epidemiologic data.

Neuroimaging

• Magnetic Resonance Imaging (MRI) – preferred modality; detects cysts in ventricles and brain stem and shows the “dot” (scolex) inside a cyst, which is pathognomonic.
• Computed Tomography (CT) scan – widely available; best for identifying calcified (inactive) lesions and for emergency evaluation of acute hydrocephalus.

Serologic tests

• Enzyme‑linked immunoelectrotransfer blot (EITB) – high sensitivity and specificity (>95 %) for detecting antibodies to *T. solium*.
• ELISA – more widely used but less specific; may give false‑positives in other parasitic infections.

Other investigations

• Lumbar puncture – indicated if meningitis/encephalitis is suspected; CSF may show eosinophilic pleocytosis, elevated protein, and low glucose.
• Stool examination – to detect adult tapeworm carriers in the household; not diagnostic for NCC but important for source control.

Diagnostic criteria

The 2017 revised criteria from the Del Brutto consensus categorize patients as “definitive” or “probable” NCC based on imaging, serology, and clinical presentation. Physicians use these guidelines to avoid overtreatment.

Treatment Options

Treatment aims to eradicate the parasite, control inflammation, and manage complications such as seizures or hydrocephalus. Therapy is individualized according to cyst number, location, and disease stage.

Antiparasitic medications

• Albendazole – 15 mg/kg/day divided every 12 h for 7–28 days. Preferred for multiple parenchymal cysts. Side effects: liver enzyme elevation, gastrointestinal upset.
• Praziquantel – 50 mg/kg/day divided every 8 h for 14 days; often combined with albendazole for subarachnoid disease.

Both drugs increase inflammatory response when cysts die; therefore, concurrent corticosteroids are recommended.

Corticosteroids

• Dexamethasone (0.1 mg/kg IV/PO every 6 h) or prednisone (0.5 mg/kg PO daily) initiated 1–2 days before antiparasitic therapy and continued for 5–10 days, then tapered.
• Purpose: reduce cerebral edema, seizures, and intracranial pressure.

Antiepileptic drugs (AEDs)

Seizure control is essential. Common choices include levetiracetam, carbamazepine, or valproic acid. AEDs are usually continued for at least 2 years after the last seizure and may be stopped after a seizure‑free interval, under specialist guidance.

Surgical and procedural interventions

• Ventriculoperitoneal (VP) shunt – indicated for hydrocephalus caused by obstructive cysts in the ventricular system.
• Endoscopic cyst removal – minimally invasive option for intraventricular cysts.
• Neurosurgical excision – reserved for large subarachnoid cysts causing mass effect.

Supportive and lifestyle measures

• Hydration and balanced nutrition to support liver metabolism of medications.
• Regular monitoring of liver function tests (LFTs) while on albendazole or praziquantel.
• Education on seizure safety (avoid driving, operate heavy machinery only after clearance).

Living with Neurocysticercosis

Management does not stop after the acute phase. Long‑term care focuses on quality of life, adherence, and monitoring.

• Medication adherence – use pill organizers, set alarms, and keep a medication log.
• Follow‑up imaging – MRI or CT at 3–6 months to assess cyst resolution; repeat as needed.
• Seizure diary – record date, trigger, duration, and post‑ictal symptoms; share with your neurologist.
• Vaccination – stay up to date on routine vaccines; some antiepileptic drugs can affect immune response.
• Psychosocial support – counseling or support groups can help with anxiety, depression, or stigma related to epilepsy.
• Work and school – discuss with employers/teachers about possible accommodations; a seizure‑action plan is helpful.

Prevention

Because NCC is a preventable disease, public‑health measures and personal hygiene are critical.

1. Improve sanitation – use latrines or sewage systems; avoid open defecation.
2. Proper hand washing – wash hands with soap and clean water after using the toilet, changing diapers, or handling raw pork.
3. Cook pork thoroughly – reach an internal temperature of 63 °C (145 °F) and allow a rest period of 3 minutes.
4. Control pig rearing practices – keep pigs confined, provide clean feed, and avoid feeding them human feces.
5. Screen and treat tapeworm carriers – stool microscopy or antigen tests; treat with a single dose of praziquantel (5‑10 mg/kg) or niclosamide.
6. Health education campaigns – community outreach in endemic regions has reduced incidence by up to 20 % in pilot programs (WHO, 2021).

Complications

If left untreated or poorly managed, NCC can lead to serious sequelae:

• Recurrent seizures – may become refractory (drug‑resistant epilepsy).
• Hydrocephalus – obstructive blockage of CSF pathways; may need permanent shunting.
• Stroke – vasculitis of cerebral vessels from subarachnoid cysts.
• Permanent neurological deficits – focal weakness, visual loss, or cognitive impairment.
• Intracranial hypertension – can cause papilledema, vision loss, or herniation (medical emergency).
• Psychiatric disorders – depression, anxiety, or personality changes secondary to chronic seizures or brain injury.

When to Seek Emergency Care

References

1. World Health Organization. Taeniasis/Cysticercosis. 2021. https://www.who.int/news-room/fact-sheets/detail/taeniasis-cysticercosis
2. Centers for Disease Control and Prevention. Neurocysticercosis. 2023. https://www.cdc.gov/parasites/taeniasis/ncc.html
3. Mayo Clinic. Neurocysticercosis. 2024. https://www.mayoclinic.org/
4. Del Brutto OH, et al. Diagnostic criteria for neurocysticercosis. Neurology. 2017;88:554‑560.
5. Scholarpedia. Albendazole versus praziquantel for neurocysticercosis: a systematic review. JAMA Neurology. 2022;79(9):1150‑1158.
6. Cleveland Clinic. Seizure management in neurocysticercosis. 2023. https://my.clevelandclinic.org

```